Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC Opens Registration for Free European Market Access Training Program Cohort Starting 16 July 2026

MTRC has opened registration for the next cohort of its free European Market Access Training Program for MedTech professionals, starting on 16 July 2026.

The program is designed for professionals looking to strengthen their understanding of reimbursement systems, HTA requirements, and market access pathways across Europe. Developed by MTRC experts based on years of consulting experience, the training provides a practical introduction to healthcare funding and reimbursement for medical technologies in key European markets, including England, Germany, France, and Italy.

The 8-week online program combines self-paced learning with expert interaction and includes webinars, course materials, quizzes, live discussions, practical examples, and an optional hands-on market access analysis project.

Participants will gain insights into:

  • European reimbursement systems for MedTech
  • HTA and payer decision-making processes
  • Clinical and health economic evidence requirements
  • Country-specific market access pathways across major EU markets

The entire program is offered free of charge to MedTech industry professionals as part of MTRC’s knowledge-sharing initiative.

In addition to the cohort-based format, MTRC also offers instant-access corporate licenses and customized internal training programs for MedTech companies seeking scalable market access education solutions for their teams.

Learn more and contact us to join the upcoming cohort starting on 16 July 2026.